QuantLogix

MRNA vs PFE — live signal comparison

Head-to-head on QuantLogix's 5-factor quant engine, recomputed throughout the trading day. An engine-read comparison — not a recommendation.

MRNA
Moderna, Inc. Common Stock
54/100
BUY
$49.91 · +0.47% · $19.7B
Full scorecard →
VS
engine lead
PFE
Pfizer Inc.
57/100
BUY
$26.21 · +0.14% · $149.2B
62% of similar setups up in 5d
Full scorecard →
Factor by factor — MRNA (left) vs PFE (right)
62
Technical
64
53
Momentum
50
25
Fundamental
54
76
Options
60

QuantLogix's 5-factor engine currently reads Moderna, Inc. Common Stock (MRNA) at 54/100 (buy) and Pfizer Inc. (PFE) at 57/100 (buy). PFE carries the stronger composite read by 3 points, led by technical at 64/100. MRNA's strongest leg is options at 76/100. Signals recompute throughout the trading day — the balance can shift with the tape.

Track PFE with free signal alerts Browse all scorecards
🤖 Want the deeper take? Pro runs a 10-agent AI debate on either name — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

Educational market analysis, not investment advice. QuantLogix does not provide personalized recommendations. MRNA scorecard · PFE scorecard · MRNA earnings · PFE earnings · Today's movers · Verified track record